Master of Science (MS) (Regulatory Science (FDA Law))
2007 - 2009
Maurice A. Deane School of Law at Hofstra University
Doctor of Law (J.D.) (Intellectual Property)
2003 - 2006
New Jersey Institute of Technology
Master's degree (Biomathematics, Bioinformatics, and Computational Biology)
2005 - 2008
The University of Texas at Dallas
Master of Science (MS) (Neurobiology and Neurosciences)
2005 - 2008
University of Texas at Dallas - Naveen Jindal School of Management
Master of Business Administration (M.B.A.) (Entrepreneurship/Entrepreneurial Studies)
2001 - 2003
University of Texas at Dallas - Naveen Jindal School of Management
Master's degree (Accounting and Finance)
2001 - 2003
The University of Dallas
Bachelor of Arts (B.A.) (Economics)
2000 - 2001
2008
Will Rosellini's Skills
Strategy
Life Sciences
R&D
Start-ups
Commercialization
Management
Entrepreneurship
Strategic Planning
Venture Capital
Medical Devices
Will Rosellini's Summary
Will Rosellini, based in United States, is currently a President at CytoImmune Therapeutics, bringing experience from previous roles at Perimeter Medical Imaging AI, Nexeon MedSystems, Inc., Texas Biomedical Device Center and Lexington Technology Group, LLC (exit to Document Security Systems "DSS"). Will Rosellini holds a 2007 - 2009 Master of Science (MS) in Regulatory Science (FDA Law) @ University of Southern California. With a robust skill set that includes Strategy, Life Sciences, R&D, Start-ups, Commercialization and more, Will Rosellini contributes valuable insights to the industry. Will Rosellini has 1 email and 1 mobile phone number on RocketReach.